Myeloid neoplasms Archives - Insights https://news.mayocliniclabs.com/category/hematology/myeloid-neoplasms/ Get the latest news and education from Mayo Clinic Laboratories Tue, 30 Apr 2024 15:50:21 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.1 Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D. https://news.mayocliniclabs.com/2024/04/30/assay-provides-quick-diagnosis-of-vexas-syndrome-david-s-viswanatha-m-d/ https://news.mayocliniclabs.com/2024/04/30/assay-provides-quick-diagnosis-of-vexas-syndrome-david-s-viswanatha-m-d/#respond Tue, 30 Apr 2024 13:00:00 +0000 https://news.mayocliniclabs.com/?p=110290 Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the syndrome, which severely impacts multiple organs and blood.

The post Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/04/30/assay-provides-quick-diagnosis-of-vexas-syndrome-david-s-viswanatha-m-d/feed/ 0 BCR/ABL1 Testing [Test in Focus] https://news.mayocliniclabs.com/2019/07/16/bcr-abl1/ https://news.mayocliniclabs.com/2019/07/16/bcr-abl1/#respond Tue, 16 Jul 2019 16:35:44 +0000 https://news.mayocliniclabs.com/?p=52159 BCR/ABL1 Testing [Test in Focus]David Viswanatha, M.D., a hematopathologist and co-director of the molecular hematology and complete genome sequencing laboratories at Mayo Clinic, provides an overview of BCR/ABL1 testing, discusses the best testing methods, NCCN/ELN criteria guidelines, why FISH testing is no longer routinely available at Mayo Clinic, and what test to order at what time for CML patients.

The post BCR/ABL1 Testing [Test in Focus] appeared first on Insights.

]]> https://news.mayocliniclabs.com/2019/07/16/bcr-abl1/feed/ 0